Percheron Therapeutics Limited
PERCF
$0.0025
-$0.0165-86.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -43.45% | -23.14% | -2.07% | -13.00% | -29.65% |
| Total Depreciation and Amortization | -28.68% | -23.22% | -18.75% | -10.47% | -1.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 110.76% | 119.32% | 12.84% | -163.95% | -172.85% |
| Change in Net Operating Assets | -49.48% | -49.48% | -49.48% | 585.23% | 225.17% |
| Cash from Operations | -32.56% | -28.15% | -20.74% | -31.32% | -45.22% |
| Capital Expenditure | 67.82% | 82.27% | 88.32% | 70.90% | 51.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 67.82% | 82.27% | 88.32% | 70.90% | 51.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 8.04% | 1.53% | -4.93% | -3.57% | -2.17% |
| Issuance of Common Stock | 28.07% | 128.07% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -27.75% | -112.77% | -- | -7,704.17% | -4,209.72% |
| Cash from Financing | 29.88% | 133.53% | 12,618.96% | 13,784.16% | 15,232.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.87% | 114.09% | 110.06% | 108.20% | 105.10% |